Peer-reviewed veterinary case report
Nasal transmissible venereal tumors causing bleeding in 12 dogs
By Ignatenko, Nataliia et al.·Published in Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere·2020·Clinic of Small Animal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Nasal transmissible venereal tumours in 12 dogs - a retrospective study.
- Species:
- dog
Plain-English summary
Twelve dogs with nasal transmissible venereal tumors (TVT) were treated after showing symptoms like sneezing and nasal bleeding. Most of these dogs were between 3 to 7 years old and came from Ukraine. They received a weekly treatment of vincristine sulfate for about 4 to 9 cycles, and all dogs responded well, achieving complete remission. During a follow-up period of nearly two years, all dogs remained disease-free and tolerated the treatment without issues.
People also search for: dog sneezing and nasal bleeding · vincristine treatment for dog tumors · nasal tumors in dogs
Abstract
OBJECTIVE: The aim of this study was a retrospective analysis of clinical manifestation and treatment outcome of the nasal form of transmissible venereal tumours (TVT). MATERIAL AND METHODS: Twelve dogs suffering from nasal TVT were included in this study. Patients with primary genital lesions were excluded from the study. Signalment, physical examination and laboratory findings, results of further diagnostics, and treatment results were recorded in all patients. RESULTS: The study population comprised 9 male and 4 female dogs with an (estimated) age ranging from 3 to 7 years. With one exception all dogs originated from Ukraine. Symptoms of nasal TVT included sneezing, nasal bleeding (all cases), skull infiltration (9 cases), oronasal fistulas (9 cases) and cutaneous fistulas (5 cases). Animals received vincristine sulfate at 0.7 mg/mi. v. weekly. The treatment course consisted of 4-9 cycles (median 5 cycles). Complete remission was achieved in all cases. All dogs were disease-free during the follow-up period (median 23.5 months, range 12-56 months). All patients tolerated the treatment very well. CLINICAL SIGNIFICANCE: In conclusion, our data suggest that nasal TVT can have a good response to vincristine treatment. TVT should be considered as a differential diagnosis in sneezing dogs with nasal discharge or bleeding especially in young dogs and in dogs with suspected nasal tumours, even in countries without a stray animal population.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32557494/